Stock listing

F6T Stock Price, News, Filings & Events — Fate Therapeutics, Inc.

Selected listing: F6T · TRADEGATE · EUR · DE

F6T:TRADEGATE represents Fate Therapeutics, Inc., a biotechnology company focused on developing cellular immunotherapies for cancer and immune disorders. The company is advancing its innovative therapies through clinical trials and has been actively engaging with the market through recent news and filings. Investors can stay updated on upcoming events and developments that may impact the company's growth and market position.

F6T:TRADEGATEEURDEUpdated July 24, 2026
Fate Therapeutics, Inc. logo
Ticker
F6T:TRADEGATE
Asset type
Stock
Market cap
$280.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
TRADEGATE
Currency
EUR

Fate Therapeutics, Inc. F6T:TRADEGATE stock context

F6T:TRADEGATE represents Fate Therapeutics, Inc., a biotechnology company focused on developing cellular immunotherapies for cancer and immune disorders. The company is advancing its innovative therapies through clinical trials and has been actively engaging with the market through recent news and filings. Investors can stay updated on upcoming events and developments that may impact the company's growth and market position.

Research Fate Therapeutics, Inc.

Alternate listings